Key Takeaways
LifeStance Health Group Inc. (LFST) reported first-quarter revenue of $403.5 million, beating Wall Street estimates and sending its stock higher despite a planned secondary offering by existing shareholders.
“Our performance demonstrates that our differentiated model is meeting the societal trend of growing demand for mental healthcare,” said Dave Bourdon, CEO of LifeStance, in a statement.
The outpatient mental health provider exceeded analyst expectations for both revenue and profit. The results compare favorably to the prior-year period, showing significant growth in key financial metrics.
The strong results overshadowed an announcement that certain stockholders intend to offer 35,000,000 shares of common stock. The company clarified it is not selling any shares in the offering and will not receive any proceeds from the sale.
For the second quarter, LifeStance said it expects revenue in the range of $405 million to $425 million. The company also provided a full-year 2026 revenue outlook of between $1.64 billion and $1.68 billion.
The 48 percent growth in Adjusted EBITDA to $51.1 million points to improving operational efficiency and profitability. The company's performance suggests a strong start to the year, capitalizing on the increasing demand for mental health services.
The guidance indicates management's confidence in sustained growth through the rest of the year. Investors will next look to the company's second-quarter results, expected in August, for confirmation that this growth trajectory is continuing.
This article is for informational purposes only and does not constitute investment advice.
